The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia.
Sordo-Bahamonde C, Martínez-Pérez A, Granda-Díaz R, Pascual J, Aguilar-García C, González-Rodríguez AP, González-García E, Beltrán DC, Bras LM, Payer ÁR, Lorenzo-Herrero S, Gonzalez S. Biomed Pharmacother. 2025 Jun 13;189:118253. doi: 10.1016/j.biopha.2025.118253. Online ahead of print. PMID: 40516328 Free article. La revista National Library of Medicine (National Center for Biotechnology Information) se [...]